UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER
DEAD

Serial Number

97772311

Owner

Siren Biotechnology, Inc.

Filing Date

Jan 30, 2023

Add to watchlist:

No watchlists yet
View on USPTO

UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER Trademark

Serial Number: 97772311

UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER is a trademark filed by Siren Biotechnology, Inc. on January 30, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Siren Biotechnology, Inc. (17 trademarks)

953 Indiana Street
San Francisco, CA 94107

Entity Type: 03

Trademark Details

Filing Date

January 30, 2023

Registration Date

Not Registered

Goods & Services

Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 14, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 14, 2024 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 31, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 31, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 31, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 27, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 16, 2023 NWOS
NEW APPLICATION ENTERED
Feb 2, 2023 NWAP